Enfilcon A
drugOn this page
Summary
Enfilcon A (CHEMBL2108028) is a phase-3 clinical-stage small molecule.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Small molecule
- Clinical trials: 8
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108028 |
| Name | Enfilcon A |
| Type | Small molecule |
| Max phase | 3 |
Also known as: Enfilcon a, ENFILCON A
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indications (0 at ChEMBL trial phase 4).
Clinical trials
Total trials: 8.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 8 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01010555 | Not specified | COMPLETED | In-vivo Wettability Grading and Assessment Study |
| NCT01582789 | Not specified | COMPLETED | Comparative Study of Two Marketed Spherical Soft Contact Lenses |
| NCT01706770 | Not specified | COMPLETED | Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens |
| NCT02142361 | Not specified | COMPLETED | Clinical Performance of Habitual Hydrogel vs. Silicone Hydrogel Toric Contact Lenses |
| NCT02356692 | Not specified | COMPLETED | Clinical Comfort Evaluation of Two Marketed Spherical Contact Lenses |
| NCT02423109 | Not specified | COMPLETED | Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses |
| NCT02518490 | Not specified | COMPLETED | A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens |
| NCT02537717 | Not specified | COMPLETED | A Contralateral Dispensing Clinical Trial of Study Test Silicone Hydrogel Lens Against Enfilcon A Silicone Hydrogel Lens |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.